Antibiotic Management in Bronchiectasis.

Anti-Bacterial Agents / therapeutic use Bronchiectasis / drug therapy Humans
Antibiotics Bronchiectasis Chronic suppressive Eradication Exacerbation Intravenous Nebulized Oral

Journal

Clinics in chest medicine
ISSN: 1557-8216
Titre abrégé: Clin Chest Med
Pays: United States
ID NLM: 7907612

Informations de publication

Date de publication:
03 2022
Historique:
entrez: 3 3 2022
pubmed: 4 3 2022
medline: 6 5 2022
Statut: ppublish

Résumé

Antibiotics are an essential component of the management of patients with bronchiectasis. This article reviews the role of antibiotics in the treatment of exacerbations, for maintenance therapy to reduce exacerbation frequency, and for eradicating potentially harmful organisms such as Pseudomonas aeruginosa.

Identifiants

DOI: 10.1016/j.ccm.2021.11.009 PMID: 35236556
pubmed: 35236556
pii: S0272-5231(21)01247-8
doi: 10.1016/j.ccm.2021.11.009
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

165-177

Informations de copyright

Crown Copyright © 2021. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure C.S. Haworth received consultancy/advisory board fees from Abbvie, Aradigm, Chiesi, CSL Behring, Gilead, Grifols, GSK, Profile, Insmed, Janssen, Meiji, Mylan, Novartis, Shionogi, Teva, Vertex, and Zambon. R.A. Floto received consultancy/advisory board fees from Chiesi, Gilead, GSK, Insmed, Teva, and Vertex; and research funding from GSK, AstraZeneca, Insmed, and Vertex.

Auteurs

Charles S Haworth (CS)

Cambridge Centre for Lung Infection, Royal Papworth Hospital, Cambridge CB2 0AY, UK; Department of Medicine, University of Cambridge, Cambridge, UK. Electronic address: charles.haworth@nhs.net.

Roderigo Andres Floto (RA)

Cambridge Centre for Lung Infection, Royal Papworth Hospital, Cambridge CB2 0AY, UK; University of Cambridge Molecular Immunity Unit, MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Antibiotic Management in Bronchiectasis.
questionsmedicales.fr › Maladies de l'appareil respiratoire › Maladies des bronches › Dilatation des bronches › Antibiotic Management in Bronchiectasis.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Antibiotic Management in Bronchiectasis.